Submitted: 28 Aug 2018
Revised: 24 Nov 2018
Accepted: 26 Nov 2018
First published online: 30 Nov 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Int J Enteric Pathog. 2018;6(4):113-117.
doi: 10.15171/ijep.2018.28
  Abstract View: 20
  PDF Download: 22

Original Article

Protective Activity of Probiotic Bacteria Against Candida albicans: An In Vitro Study

Mahboobeh Mehrabani Natanzi 1 ORCiD, Mahsa Emampour 1, Ahmadreza Mirzaei 2, Enayatollah Kalantar 3, Zohreh Khodaii 4 * ORCiD

1 Evidence-Based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran
2 Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran
3 Department of Microbiology and Immunology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
4 Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran
*Corresponding Author: Zohreh Khodaii (M.D., Ph.D.), Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran. Phone: +98 26344584919, Fax: +98 263 44584919 Email: zkhodaii@yahoo.com

Abstract

Background: Therapeutic applications of probiotics against human candida infections remain controversial. Candida species are the most common human fungal pathogens that cause both superficial and systemic infection. Given the low number of appropriate and effective antifungal drugs, the continuing increase in the incidence of Candida infections, and increased drug resistance, it is required to explore new and better factors targeting essential biological processes and pathogenic determinants of C. albicans.

Objective: In this context, a laboratory study was conducted to investigate the effects of probiotic Lactobacillus acidophilus on the adherence of C. albicans to the human epithelial cell line known as human epithelial type 2 (HEp-2) cells and the potential protective effects of probiotic bacteria on the infected cells.

Materials and Methods: To evaluate the effect of L. acidophilus on the adherence of C. albicans to HEp-2 cells, either yeast cells, probiotic bacteria, or both were added to each well of a 12-well plate, with a coverslip at the bottom, covered with a semiconfluent layer of HEp-2 cells. After 2 hours of incubation, the number of adhered pathogens was counted using light microscopy. In order to determine the effect of C. albicans on the viability of the HEp-2 cells, in the presence and absence of L. acidophilus, MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) assay was conducted.

Results: The results revealed that either L. acidophilus strain La5 or C. albicans adhered to the (HEp-2) cells. In addition, cell association of C. albicans with Hep2 cells decreased by up to 80% when probiotic bacteria were added. The most interesting finding was that in the presence of L. acidophilus La-5, a significant decrease was observed in the adhesion of C. albicans to the cell line or cell mortality.

Conclusion: According to the results of the study, the use of probiotics is a promising method to decrease the pathogenicity of opportunistic mycoses.

First name
 
Last name
 
Email address
 
Comments
 
Security code